Valuation: Becton, Dickinson and Company

Market Cap 48.76B 43.31B 40.5B 36.91B 69.48B 4,694B 70.43B 490B 190B 2,391B 183B 179B 7,679B P/E 2026 *
34.3x
P/E 2027 * 19.1x
Enterprise Value 64.64B 57.42B 53.69B 48.93B 92.12B 6,224B 93.38B 650B 251B 3,170B 243B 237B 10,181B EV / Sales 2026 *
3.35x
EV / Sales 2027 * 3.18x
Free-Float
73.18%
Yield 2026 *
2.2%
Yield 2027 * 2.24%
1 day-1.44%
1 week-2.08%
Current month-0.55%
1 month-4.69%
3 months+17.91%
6 months+14.51%
Current year-8.44%
1 week 177.59
Extreme 177.59
187.5
1 month 174.85
Extreme 174.85
193
Current year 139.58
Extreme 139.58
212.51
1 year 139.58
Extreme 139.58
212.51
3 years 139.58
Extreme 139.58
269.21
5 years 139.58
Extreme 139.58
286.33
10 years 139.58
Extreme 139.58
286.33
Manager TitleAgeSince
Chief Executive Officer 53 28/01/2020
Director of Finance/CFO 44 05/12/2025
Chief Tech/Sci/R&D Officer 56 04/12/2023
Director TitleAgeSince
Director/Board Member 75 24/09/2002
Director/Board Member 71 26/07/2010
Chairman 53 28/04/2021
Change 5-day change 1-year change 3-year change Capi.($)
-1.44%-2.08% - - 48.76B
-2.17%-6.57%-27.81%-0.17% 171B
+0.17%-3.20%-9.24%+10.31% 110B
-0.88%-0.16%-26.16%-0.11% 106B
-0.69%-3.57%-47.61%-12.45% 75.99B
+3.17%-0.80%-0.88%+72.13% 57.3B
-0.52%-2.44%-4.86%-31.12% 48.76B
+3.44%+7.90%+19.12%+59.15% 50.19B
-0.85%-0.82%-18.96%+18.41% 41.14B
-0.07%-1.71%+28.15%-7.58% 32.56B
Average +0.25%-1.46%-9.81%+12.06% 77B
Weighted average by Cap. -0.00%-2.07%-16.38%+9.01%

Financials

2026 *2027 *
Net sales 19.28B 17.12B 16.01B 14.59B 27.47B 1,856B 27.85B 194B 74.98B 945B 72.37B 70.81B 3,036B 19.73B 17.53B 16.39B 14.94B 28.12B 1,900B 28.51B 198B 76.76B 968B 74.09B 72.48B 3,108B
Net income 1.44B 1.28B 1.19B 1.09B 2.05B 138B 2.08B 14.44B 5.59B 70.44B 5.39B 5.28B 226B 2.34B 2.08B 1.94B 1.77B 3.33B 225B 3.38B 23.51B 9.1B 115B 8.78B 8.59B 368B
Net Debt 15.88B 14.11B 13.19B 12.02B 22.64B 1,529B 22.95B 160B 61.79B 779B 59.64B 58.35B 2,502B 13.95B 12.39B 11.59B 10.56B 19.88B 1,343B 20.15B 140B 54.27B 684B 52.38B 51.25B 2,197B
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
01/10/26 $179.11 -1.44% 25
30/09/26 $180.10 -0.88% 89
29/09/26 $181.69 -0.98% 100
28/09/26 $183.48 +0.27% 866
25/09/26 $182.98 +1.63% 97
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
179.00USD
Average target price
195.67USD
Spread / Average Target
+9.31%

Quarterly revenue - Rate of surprise